Back

Met-HeFT meta-analysis: Metformin in heart failure and ischemic heart disease: a systematic review and meta-analyses

30 August 2026 (08:53 - 09:01)
Organised by: Logo
Congress Presentation Part of: HOT LINE 6 Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Anders Hostrup Larsen

Goedstrup Hospital, Herning (Denmark)

14 More presentations in this session

Presentation thumbnail
H-HeFT: Hydralazin-Isosorbide Dinitrate in HFrEF
Professor L. Kober (Copenhagen, DK)
Slides Video
Presentation thumbnail
H-ISDN Meta-Analysis: Hydralazine-Isosorbide Dinitrate in HFrEF
Doctor J. Butt (Copenhagen, DK)
Slides Video
Presentation thumbnail
Discussant review - H-HeFT, H-ISDN Meta-Analysis
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
Panel discussion - H-HeFT, H-ISDN Meta-Analysis
Presentation thumbnail
Met-HeFT: Metformin and chronic heart failure
Professor H. Wiggers (Aarhus, DK)
Slides Video

Access the full session

Session thumbnail
HOT LINE 6
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 08:53 CET
You may be interested in
thumbnail
Congress Presentation
Impact of LVEF and de novo heart failure on outcomes of SGLT2 inhibitor therapy initiated during acute heart failure
11 May 2026
thumbnail
Congress Presentation
All diabetic patients should be treated with metformin.
29 August 2022
thumbnail
Congress Presentation
Metformin associated lower risk of dementia among heart failure patients: a population-based retrospective cohort study
17 May 2025
thumbnail
Congress Presentation
Impact of metformin on the all-cause mortality in diabetic patients hospitalized with acute heart failure
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources